Albuked human

You should not receive albumin if you have severe anemia (lack of red blood cells), or severe heart failure.

Albumin is injected into a vein through an IV. A healthcare provider will give you this injection.

Your breathing, pulse, blood pressure, electrolyte levels, kidney function, and other vital signs will be watched closely while you are receiving albumin. Your blood will also need to be tested regularly during treatment.

Drink plenty of liquids while you are being treated with albumin.

Other drugs may interact with albumin, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your health care providers about all medicines you use now and any medicine you start or stop using.

Applies to albumin human: intravenous solution

Dermatologic

Dermatologic side effects have included urticaria, skin rash, pruritus, edema, and erythema.[Ref]

Nervous system

Nervous system side effects have included headache, chills, and febrile reactions.[Ref]

Cardiovascular

Cardiovascular side effects have included hypotension.[Ref]

Gastrointestinal

Gastrointestinal side effects have included nausea, vomiting and increased salivation.[Ref]

Respiratory

Respiratory side effects have included bronchospasm.[Ref]

Some side effects of Albuked may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.

Albumin 5%:

Initial dose: 250 or 500 mL IV at a rate of 1 to 2 mL per minute in the absence of overt shock. The capacity of the administration set is the only limit in the exsanguinated patient. The rate of infusion and total volume administered are determined by the condition and response of the patient. The initial dose may be followed by additional albumin within 15 to 30 minutes if the response is inadequate.

Albumin 25%:

Initial dose: The patient may require 200 to 300 mL IV to reduce edema and to bring serum protein values to normal. Since such patients usually have approximately normal blood volume, doses of more than 100 mL of albumin 25% should not be given faster than 100 mL IV over 30 to 45 minutes to avoid circulatory overload. If slower administration is desired, 200 mL of albumin 25% may be mixed with 300 mL of 10% dextrose solution and administered by continuous drip at a rate of 100 mL an hour IV.

Albumin 5%:

Initial dose: 10 to 15 mL per pound (4.5 to 6.8 mL per kg) of body weight IV is usually adequate accompanied by close surveillance of the child.

Albumin 5%:

Initial dose: 10 to 15 mL per pound (4.5 to 6.8 mL per kg) of body weight IV is usually adequate accompanied by close surveillance of the child.

Data not available

There are no data on the excretion of albumin into human milk.